av Eirik A. Torheim | nov 10, 2023
Background Glaucoma is a multifactorial optic neuropathy characterized by progressive damage to the optic nerve, which results in the loss of retinal ganglion cells. Increased intraocular pressure (IOP) is an important risk factor. Treatment is directed at lowering...
av Elin Melby | nov 9, 2021
Business opportunity Brain tumors are one of the deadliest forms of cancer and the primary goal of treatment is simply to decelerate tumor growth. Still, after decades of research, only about half of the patients respond to any form of treatment and the survival...
av Elin Melby | nov 8, 2021
Business opportunity Heart failure is one of the most prevalent heart diseases, affecting over 64 million people worldwide, and has a mortality as high as severe types of cancer. Heart failure is however a heterogeneous syndrome, and case ascertainment and...
av Elin Melby | apr 12, 2021
Business opportunity Scientists at the Inst. of Clin. Med., Univ. of Oslo, Akershus Univ. Hospital, and Faculty of Med., Univ. of Geneva are developing a tool for fully automated segmentation (creation of 3D models) and labelling of all blood vessels in a few...
av Janncike Kristoffersen | aug 16, 2020
Business opportunity Nerve injuries related to peripheral nerve blocks can be caused by toxicity of the injected solution or by mechanical nerve damage. In the worst cases, nerve damage can lead to persistent motor or sensory impairment and debilitating neuropathic...
